Sfoglia per AUTORE
MARASCA R
Collezione AOU Novara

  

Items : 20

Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort. in Blood advances / Blood Adv. 2025 Apr 16:bloodadvances.2025015818. doi: 10.1182/bloodadvances.2025015818.
2025
AOU Novara

Serafin A; Cellini A; Martino EA; Mazzetto F; Angotzi F; Frustaci AM; Marchetti M; Moia R; Sanna A; Riemma C; Cibien F; Noto A; Lista E; Foglietta M; Vitale C; Innao V; Bullo M; Lovato E; Ferrarini I; Andriola C; Ballotta L; Innocenti I; Fresa A; Favrin G; Varettoni M; Santambrogio E; Orsucci L; Pasquale R; Moratti M; et alii...

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib. in Blood advances / Blood Adv. 2023 Jun 27;7(12):2794-2806. doi: 10.1182/bloodadvances.2022008821.
2023
AOU Città della Salute di Torino
AOU Novara

Österborg A; Walewska R; Pavlovsky C; Strugov V; Ysebaert L; Mulligan SP; Coscia M; Iyengar S; Frustaci AM; Jaksic O; Ringshausen I; Panayiotidis P; Forconi F; Marasca R; Tam CS; Stavroyianni N; Bödör C; Reda G; Bonello L; Trentin L; Gaidano G; Gandini F; Lyander A; Gellerbring A; Skaftason A; Foroughi-Asl H; Weström S; Pandzic T; Capasso A; et alii...

Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):201-204. doi: 10.1002/hon.3047. Epub 2022 Aug 19.
2023
AOU Città della Salute di Torino
AOU Novara

Foà R; Moia R; Cuneo A; Reda G; Gottardi D; Chiurazzi F; Orsucci L; Maccaferri M; De Paoli L; Marasca R; Ballotta L;

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Stamatopoulos K; Ghia P; Stavroyianni N; Trentin L; Cuneo A; Montserrat E; Vitale C; Coscia M; Rambaldi A; Iyengar S; Varettoni M; Yassin M; Pocali B; Vandenberghe E; van Kampen R; et alii...

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.
2023
AOU Novara

Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.
2021
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Penna G; Chiarenza A; Foà R; Derenzini E; Levato L; Orsucci L; Gottardi D; Gattei V; Gozzetti A; Gentile M; Sanna A; Olivieri J; Murru R; Stefoni V; Leone M; Baratè C; Marasca R; Malerba L; Ibatici A; Tisi MC; Chiurazzi F; Varettoni M; Del Poeta G; Marchetti M; Farina L; Giordano A; Foglietta M; Re F; De Paoli L; et alii...

2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Piciocchi A; Cuneo A; Foà R; Rigolin GM; Fazi P; Neri A; Guarini A; Raponi S; Nanni M; De Propris MS; Della Starza I; Ibatici A; Murru R; Ruocco V; Del Giudice I; Varettoni M; Molinari A; Gentile M; Chiarenza A; Laurenti L; Gottardi D; Zinzani PL; Gozzetti A; Tani M; Musuraca G; Orsucci L; Re F; Di Renzo N; Liberati AM; et alii...

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. in Leukemia / Leukemia. 2021 Dec;35(12):3444-3454. doi: 10.1038/s41375-021-01450-8. Epub 2021 Nov 1.
2021
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Ghia P; Stamatopoulos K; Foà R; Cuneo A; Montserrat E; Rambaldi A; Coscia M; Yassin M; San Segundo LY; Wasik-Szczepanek E; Wróbel T; Visentin A; Vitale C; van Gelder M; van Kampen R; Varettoni M; Van Der Spek E; Trentin L; Tonino SH; Te Raa D; Tadmor T; Špa?ek M; Sportoletti P; Stavroyianni N; Stanca O; Shrestha A; Šimkovi? M; Saghumyan G; Qvist K; et alii...

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.
2021
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Foà R; Cuneo A; Vignetti M; Gentile M; Montillo M; Marchetti M; Mauro FR; Crea E; Marasca R; Quaglia FM; Laurenti L; Molinari AL; Paolini R; Pietrasanta D; Sportoletti P; Varettoni M; Farina L; Murru R; Gaidano G; Cibien F; Vitagliano O; Coscia M; Zamprogna G; Visentin A; Reda G; Arena V; Cavazzini F; Piciocchi A; Rigolin GM; et alii...

2020
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Ghia P; Cuneo A; Foà R; Montserrat E; Rambaldi A; Rossi G; Stamatopoulos K; Coscia M; Tam C; Zdrenghea M; Strugov V; Stavroyianni N; Stanca O; Shrestha A; Shah N; Rossi D; Papaioannou M; Ortiz Pareja M; Kalashnikova O; Enrico A; Hakobyan Y; Doubek M; Dimou M; Andres M; Nikitin E; Dos Santos G; Chiarenza A; Barna G; Pocali B; et alii...

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.
2020
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Foà R; Laurenti L; Marasca R; Mauro FR; Trentin L; Gattei V; Ibatici A; Orsucci L; Rigolin GM; Pietrasanta D; Re F; De Paoli L; Marchetti M; Varettoni M; Quaglia FM; Reda G; Scarfò L; Cuneo A;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara

Rossi D; Gaidano G; Foà R; Deaglio S; Catherwood M; Boldorini RL; Gattei V; Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; et alii...

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.
2019
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Soverini S; Vigneri P; Rosti G; Russo D; Saglio G; Castagnetti F; Pane F; Breccia M; Bonifacio M; Tomassetti S; Trabacchi E; Spadano R; Tiribelli M; Stagno F; Sancetta R; Sica S; Rege-Cambrin G; Rupoli S; Salvucci M; Rapezzi D; Pregno P; Palmieri F; Musolino C; Miggiano MC; Montefusco E; Melpignano A; Martino B; Marasca R; Lunghi M; et alii...

2018
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Ghia P; Moreno C; Foà R; de la Serna J; Vignetti M; Kennedy B; Bowles KM; Eyre TA; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Gaidano G; Re F; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Billio A; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...

The genetics of nodal marginal zone lymphoma. in Blood / Blood. 2016 Sep 8;128(10):1362-73. doi: 10.1182/blood-2016-02-696757. Epub 2016 Jun 22.
2016
AOU Novara

Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D; et alii...

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.
2015
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Gaidano G; Gattei V; Foà R; Cuneo A; Montillo M; Massaia M; Zinzani PL; Del Poeta G; Perbellini O; Moreno C; Marasca R; Tedeschi A; Neri A; Motta M; Coscia M; Rigolin GM; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Morabito F; Cortelezzi A; Mauro FR; Visco C; Chiarenza A; Bulian P; Ghilardi G; et alii...

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. in Blood / Blood. 2015 Mar 19;125(12):1922-31. doi: 10.1182/blood-2014-08-596247. Epub 2015 Jan 22.
2015
AOU Novara

Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F;

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. in Leukemia / Leukemia. 2015 Feb;29(2):503-7. doi: 10.1038/leu.2014.294. Epub 2014 Oct 6.
2015
AOU Novara

Piva R; Deaglio S; Famà R; Buonincontri R; Scarfò I; Bruscaggin A; Mereu E; Serra S; Spina V; Brusa D; Garaffo G; Monti S; Dal Bo M; Marasca R; Arcaini L; Neri A; Gattei V; Paulli M; Tiacci E; Bertoni F; Pileri SA; Foà R; Inghirami G; Gaidano G; Rossi D;

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.
2014
AOU Novara

Cortelezzi A; Sciumè M; Liberati AM; Vincenti D; Cuneo A; Reda G; Laurenti L; Zaja F; Marasca R; Chiarenza A; Gritti G; Orsucci L; Storti S; Angelucci E; Cascavilla N; Gobbi M; Mauro FR; Morabito F; Fabris S; Piciocchi A; Vignetti M; Neri A; Rossi D; Giannarelli D; Guarini A; Foà R;